Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors. - Wikidata - awgldk - TriplyDB

Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.

Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.

http://www.wikidata.org/entity/Q33418686

about

Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella.Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.

P2860

Q33719235-6449721B-5BD9-47DF-B179-1A1056B99434 Q49017342-AAD1E9FD-D8B0-4529-9671-2B610CC9DD3D

P2860

Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.

http://www.wikidata.org/entity/Q33418686

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Salvage combined chemotherapy ...... ith advanced germ cell tumors.

@ast

Salvage combined chemotherapy ...... ith advanced germ cell tumors.

@en

type

label

Salvage combined chemotherapy ...... ith advanced germ cell tumors.

@ast

Salvage combined chemotherapy ...... ith advanced germ cell tumors.

@en

prefLabel

Salvage combined chemotherapy ...... ith advanced germ cell tumors.

@ast

Salvage combined chemotherapy ...... ith advanced germ cell tumors.

@en

P1433

Q33418686-08F36D86-DB1A-4C02-84FB-55C2AC382BD4

P1476

Q33418686-C9C8B61A-D940-4D28-B1E7-2AA7F5479D25

P2093

Q33418686-050C4F5D-0E0F-42C4-A57C-A03FB3DB33D9

Q33418686-109992DD-2EB9-421B-A951-26BD340EA94D

Q33418686-36379FB7-931C-4603-9F7E-A73BEC2A1250

Q33418686-4A458998-4246-42F4-B182-1E3C59A61DCC

Q33418686-892338A0-7C49-4726-8914-1F337BF461C4

Q33418686-9BEB81F0-14B4-4AF4-B6EE-AA83F66C3A8A

Q33418686-B6DE57B2-78CE-4B60-B0CA-95E252369AC8

Q33418686-D4463A27-B0BA-4145-8ECA-F75FE4893EE5

Q33418686-DCBC2FEA-3533-4B2A-9DC5-547F6837783B

Q33418686-F7210AE9-099C-48B2-8A63-CE3EBE2076AF

P2860

Q33418686-0AEEB084-A2A1-4861-B0E8-BAC6CAFF12C2

Q33418686-298CDE04-1C6A-4BEA-A9B7-EAF5726348FB

Q33418686-6CD05C04-18EC-4E38-A51C-29EA42E1E96A

Q33418686-8C841DB0-43F2-4F32-A32D-1BCB4114C0B5

Q33418686-A9650678-AEBF-451A-8913-DC073F510F82

Q33418686-AD317E9A-F17B-4737-ADA2-A7542C9D7426

Q33418686-BCBE4562-BB74-4021-AF5D-D1CF8404A2D8

Q33418686-C61A5A14-AB9E-4C94-AEF3-62A653F3D2A1

P304

Q33418686-B3348C9B-6DCE-476E-B4CC-DE3B7EC9AA65

P31

Q33418686-8CC32DE4-BEDF-4EF8-8B56-D2008079C1D7

P356

Q33418686-314347F9-44D9-454A-80C2-1DA51BF2C926

P433

Q33418686-64C2F145-21D3-4F7A-B181-253FB54278D4

P478

Q33418686-7B900016-4474-4358-8029-9D0151F04E3A

P577

Q33418686-633B9AEC-6C27-4851-BE21-4B76363839B8

P698

Q33418686-6FB49A32-FD87-4C71-84D3-712C3DCF6BE9

P356

P1433

International Journal of Urology

P1476

Salvage combined chemotherapy ...... ith advanced germ cell tumors.

@en

P2093

Atsuko Fujihara

http://www.w3.org/2001/XMLSchema#string

Fumiya Hongo

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Nakanishi

http://www.w3.org/2001/XMLSchema#string

Kazumi Kamoi

http://www.w3.org/2001/XMLSchema#string

Koji Okihara

http://www.w3.org/2001/XMLSchema#string

Masakatsu Oishi

http://www.w3.org/2001/XMLSchema#string

Takashi Ueda

http://www.w3.org/2001/XMLSchema#string

Terukazu Nakamura

http://www.w3.org/2001/XMLSchema#string

Tsuneharu Miki

http://www.w3.org/2001/XMLSchema#string

Yoshio Naya

http://www.w3.org/2001/XMLSchema#string

P2860

Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours.

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.

Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors.

Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.

P304

288-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJU.12665

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25393104

http://www.w3.org/2001/XMLSchema#string